REQUEST A DEMO
Total
USD $0.00
Search more companies

Medtide Inc. (泰德医药(浙江)股份有限公司) (China)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Medtide Inc. Profile Updated: October 14, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

Medtide Inc. (泰德医药(浙江)股份有限公司) is an enterprise located in China, with the main office in Hangzhou. The company operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on June 04, 2026. 522 (2024) employees currently work for Medtide Inc. (泰德医药(浙江)股份有限公司). From the latest financial highlights, Medtide Inc. (泰德医药(浙江)股份有限公司) reported a net sales revenue increase of 28.91% in 2025. Its total assets grew by 54.57% over the same period. In, 2025, the company’s net profit margin increased by 24.75%.

Headquarters
No. 69, 12 Street, Qiantang District
Hangzhou; Zhejiang;

Contact Details: Purchase the Medtide Inc. (泰德医药(浙江)股份有限公司) report to view the information.

Website: http://medtideinc.com

Basic Information
Total Employees:
Purchase the Medtide Inc. (泰德医药(浙江)股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Medtide Inc. (泰德医药(浙江)股份有限公司) report to view the information.
Financial Auditors:
Purchase the Medtide Inc. (泰德医药(浙江)股份有限公司) report to view the information.
Incorporation Date:
June 04, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Subsidiaries
Chinese Peptide Company
100%
Hangzhou Yuanxi Pharmaceutical Technology
100%
Company Performance
Financial values in the chart are available after Medtide Inc. (泰德医药(浙江)股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
28.91%
Total Operating Revenue
22.06%
Operating Profit
59.91%
EBITDA
48.96%
Net Profit/Loss for the Period
267.35%
Total Assets
54.57%
Total Equity
397.19%
Operating Profit Margin
7.62%
Net Profit Margin
24.75%
Return on Equity (ROE)
-4.84%
Debt / Equity
-10.97%
Quick Ratio
2.33%
Cash Ratio
2.35%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?